Abstract
Synthetically accessible novel scaffolds and chemical functional groups with drug-like properties offer an innovative approach to medicinal chemistry design. Replacement of N–alkyl substituents with the N–pentafluorosulfanyl (N–SF₅) group may help overcome the potential liabilities due to the SF5 group's larger steric volume, stronger electron-withdrawing effect, and increased lipophilicity. However, the lack of a general, operationally simple, and efficient synthetic strategy for N–SF₅ compounds has significantly hindered their evaluation as (bio)isosteres and in turn broader application. To address this, we developed a modular coupling approach using bench-stable, scalable SF₅-transfer reagents, enabling efficient access to N–SF₅-azetidines. This method provides a user-friendly protocol with mild reaction conditions and broad functional group tolerance, making it well-suited for the late-stage modification of commercial drugs and natural products. The resulting scaffolds demonstrate high aqueous stability and lipophilicity, staging them as a novel class of potential (bio)isosteres in medicinal chemistry.
Supplementary materials
Title
Supplementary Information
Description
SI
Actions



![Author ORCID: We display the ORCID iD icon alongside authors names on our website to acknowledge that the ORCiD has been authenticated when entered by the user. To view the users ORCiD record click the icon. [opens in a new tab]](https://www.cambridge.org/engage/assets/public/coe/logo/orcid.png)